Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Radiation Oncology Journal. 2022;40(2):103-110 
Adjuvant high-dose-rate intravaginal brachytherapy for intermediate- and high-risk stage IB-IIB endometrial cancer: The University of Iowa experience
Brachytherapy. 2008;7(2):153-154
Outcome after Brachytherapy Alone for Intermediate Risk Early Stage Endometrial Cancer
Brachytherapy. 2016;15:S122
511 Poster Clinical outcome of patients with intermediate-risk surgical stage I endometrial cancer treated with postoperative intravaginal brachytherapy without teletherapy
Radiotherapy and Oncology. 2002;64:S163
Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
Gynecologic Oncology. 2021;162:S146
Phase II trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early-stage endometrial cancer patients with enriched, high-intermediate risk factors for recurrence
Gynecologic Oncology. 2020;159:242
Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
Gynecologic Oncology. 2021;160(2):389-395
Intensity Modulated Radiation Therapy (IMRT) followed by Cesium-131 Brachytherapy for Intermediate and High Risk Localized Prostate Cancer
Brachytherapy. 2019;18(3):S72
Not all high-intermediate risk endometrial cancers are created equal: recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy in all possible subgroups of early-stage high-intermediate risk endometrial cancer
Gynecologic Oncology. 2021;162:S213
26 oral High dose rate vaginal brachytherapy in the management of stage I-II endometrial cancer after complete surgical staging
Radiotherapy and Oncology. 2002;63:S8-S9